WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Discover www.zeiss.de/functionality
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Montero, C. N.
Right arrow Articles by Hefti, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Montero, C. N.
Right arrow Articles by Hefti, F.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 8, 2986-2999, Copyright © 1988 by Society for Neuroscience


ARTICLE

Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment

CN Montero and F Hefti
Department of Neurology, University of Miami Medical School, Florida 33101.

We earlier reported that chronic intraventricular injections of NGF into adult rats with partial transection of the fimbria prevent the lesion-induced disappearance of cholinergic neurons in the medial septal nucleus and the diagonal band of Broca (Hefti, 1986). The present study assessed the specificity and treatment requirements of this effect of NGF. Immunohistochemical visualization of NGF receptors (NGF-R) revealed that these molecules are selectively located in forebrain cholinergic neurons of unlesioned brains. Fimbrial transection resulted in transient accumulation of NGF-R in proximal stumps of lesioned axons but failed to induce the expression of NGF-R by other cells in the septal area or near the lesion. Two to three weeks after lesioning, the number of septal neurons expressing NGF-R was reduced by approximately 50% in parallel with the reduction of the number of neurons expressing cholinergic marker enzymes. Repeated intraventricular NGF injections during 4 weeks prevented the disappearance of these cells. Fimbrial transections also reduced the number of septal GABAergic neurons visualized by glutamate decarboxylase immunohistochemistry. The loss of GABAergic neurons was not prevented by NGF. These findings suggest that NGF prevents the lesion-induced degeneration of cholinergic neurons by directly acting on NGF-R expressed by cholinergic cells and that NGF does not affect any neuron with an axonal lesion. Delayed start of the NGF treatment failed to prevent the disappearance of lesioned cholinergic neurons, providing evidence that NGF treatment indeed promotes the survival of these cells rather than simply upregulating the expression of transmitter-specific enzymes. A single injection of NGF at the time of the lesion was not sufficient to prevent the lesion-induced degeneration of cholinergic neurons. Furthermore, termination of chronic NGF treatment after 4 weeks was followed by loss of septal cholinergic neurons after an additional 4 weeks. These findings suggest that the continuous presence of NGF during more than 4 weeks is required to prevent the degeneration of cholinergic cells. The data are discussed in the context of a possible physiological role of NGF in the function of adult forebrain cholinergic neurons.


This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. Y. L. Huh, M. Danik, F. Manseau, L.-E. Trudeau, and S. Williams
Chronic Exposure to Nerve Growth Factor Increases Acetylcholine and Glutamate Release from Cholinergic Neurons of the Rat Medial Septum and Diagonal Band of Broca via Mechanisms Mediated by p75NTR
J. Neurosci., February 6, 2008; 28(6): 1404 - 1409.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. O'Meara, U. Coumis, S. Y. Ma, J. Kehr, S. Mahoney, A. Bacon, S. J. Allen, F. Holmes, U. Kahl, F. H. Wang, et al.
Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons
PNAS, September 29, 2000; (2000) 210254597.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
W. J. Friedman, S. Thakur, L. Seidman, and A. B. Rabson
Regulation of Nerve Growth Factor mRNA by Interleukin-1 in Rat Hippocampal Astrocytes Is Mediated by NFkappa B
J. Biol. Chem., December 6, 1996; 271(49): 31115 - 31120.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
S. B. Tatter, W. R. Galpern, and O. Isacson
Neurotrophic Factor Protection against Excitotoxic Neuronal Death
Neuroscientist, September 1, 1995; 1(5): 286 - 297.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. O'Meara, U. Coumis, S. Y. Ma, J. Kehr, S. Mahoney, A. Bacon, S. J. Allen, F. Holmes, U. Kahl, F. H. Wang, et al.
Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons
PNAS, October 10, 2000; 97(21): 11569 - 11574.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-